QA: Unicycive Therapeutics Inc in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001766140_2023_Unicycive_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001766140, Unicycive Therapeutics Inc

  xvar xval
0 AssetsCurrent 2,644,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 22,000
3 remainder_Assets 152,000
4 LiabilitiesCurrent 3,284,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 6,567,000
9 ResearchAndDevelopmentExpense 12,436,000
10 remainder_Expenses 0
11 remainder_Revenues 951,000
12 remainder_NetIncome -6,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 2,818,000
1 Liabilities 3,284,000
2 Expenses 19,003,000
3 Revenues 951,000
4 StockholdersEquity -466,000
5 NetIncome -18,058,000
6 ComprehensiveNetIncome -18,058,000
7 BaseVar 13,031,000
8 EconomicCapitalRatiobeforeLimitedLiability -6.25
9 EconomicCapitalRatio 0.0619

Edgar->Model Mapping

Feature Distribution